Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Pilot Study of Bevacizumab in Subjects With Choroidal Neovascularization Secondary to Diseases Other Than Age-Related Macular Degeneration

NCT00407719 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00407719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Pilot Study of Bevacizumab in Subjects With Choroidal Neovascularization Secondary to Diseases Other Than Age-Related Macular Degeneration
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2005
Completion date
May 31, 2008
Enrollment
10
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascularization, degenerative myopia, pathological myopia